Joyce Louise Smith, in Winterhaven, CA - Psychologist

Joyce Louise Smith, is a Psychologist based in Winterhaven, California. Joyce Louise Smith is licensed to practice in Arizona (license number 1706) and her current practice location is One Indian Hill Rd, Winterhaven, California. She can be reached at her office (for appointments etc.) via phone at (760) 572-4216.

NPI number for Joyce Louise Smith is 1154361822 and her current mailing address is Po Box 1368, Yuma, Arizona. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1154361822.

Contact Information

	Joyce Louise Smith,
	One Indian Hill Rd, Winterhaven, CA 92283
	(760) 572-4216
	(760) 572-4230

Healthcare Provider's Profile

Full Name	Joyce Louise Smith
Gender	Female
Speciality	Psychologist
Location	One Indian Hill Rd, Winterhaven, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1154361822
Provider Enumeration Date: 06/08/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Joyce Louise Smith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1154361822	NPI	-	NPPES
497322	Medicaid	AZ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	1706 (Arizona)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Joyce Louise Smith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Joyce Louise Smith, Po Box 1368, Yuma, AZ 85366-1368 Ph: (760) 572-4216	Joyce Louise Smith, One Indian Hill Rd, Winterhaven, CA 92283 Ph: (760) 572-4216

News Archive

Researchers discover unexpected role of mTORC2 protein in colorectal cancer

New results from researchers at MedUni Vienna's Center for Pathobiochemistry and Genetics show that a protein called mTORC2, which is the target of newly developed cancer drugs, is not even active in colorectal cancer. mTORC2 activity was only found in certain immune cells, which actually need this protein to fight cancer cells.

Spectral Diagnostics receives FDA IDE approval for Toraymyxin

BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.

Anthem Blue Cross and Blue Shield, NHCMG partner under patient-centered care agreement

Anthem Blue Cross and Blue Shield and New Haven Community Medical Group announced today that the two organizations have partnered under a patient-centered care agreement that will create an accountable care model to help ensure Anthem members' access to quality health care that is focused on improved outcomes and lower costs.

Clinical trial to test low-dose heparin treatment for patients with ruptured brain aneurysm

A Louisville patient is the first to be enrolled in a national clinical trial to test a new treatment for patients who have suffered a ruptured brain aneurysm.

Joyce Louise Smith, - Psychologist in Winterhaven, CA